USANA Health Sciences (USNA) Reports Mixed Q4 Results and Guidance

USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.65, $0.28 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $219.1 million.

USANA Health Sciences sees FY2015 EPS of $6.40-$6.70, versus the consensus of $6.73. USANA Health Sciences sees FY2015 revenue of $850-870 million, versus the consensus of $823.55 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)